Stonvex
Stonvex
StonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-13 | $30.86 | $29.44 | -4.60% | 3.8M |
| 05-14 | $29.59 | $28.94 | -2.20% | 4.7M |
| 05-15 | $29.53 | $29.05 | -1.63% | 5.6M |
| 05-18 | $29.03 | $31.35 | +7.99% | 4.1M |
| 05-19 | $31.80 | $31.67 | -0.41% | 3.4M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.30B | $5.08B | $3.76B | $2.47B |
Operating Income | $198.58M | $750.21M | $554.75M | $363.10M |
Net Income | $147.99M | $552.49M | $409.40M | $263.57M |
EPS (Diluted) | $0.86 | $3.13 | $2.31 | $1.48 |
Total Assets | $5.62B | $5.84B | $5.36B | $5.31B |
Total Liabilities | $3.14B | $3.29B | $2.82B | $2.72B |
Cash & Equivalents | $578.08M | $853.84M | $740.76M | $663.26M |
Free Cash Flow OCF − CapEx | $-47.47M | $734.65M | $465.62M | $173.60M |
Shares Outstanding | 172.85M | 170.34M | 172.41M | 174.26M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.